Intelligence Platform

Patents

Browse 45 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 10456404

Targeting cGMP-related phosphodiesterases to reduce cyst formation in cystic kidney diseas

United States Government as represented by the Department of Veterans Affairs · Granted Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10291197

Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturati

CG Discovery, Inc. · Granted Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9937217

Method of inhibiting ABCG2 and related treatments

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9687566

Low affinity FCGR deficient mice

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9657270

Human disc tissue

DiscGenics, Inc. · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9551713

Use of a panel of urinary cytokines to predict response to BCG therapy for bladder cancer

The Board of Regents of the University of Texas System · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9487753

Compositions of adult disc stem cells and methods for the treatment of degenerative disc d

DiscGenics, Inc. · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9404114

Antisense modulation of GCGR expression

Ionis Pharmaceuticals, Inc. · Granted Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9314448

Method of inhibiting ABCG2 and other treatment methods

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9114102

Method of inhibiting ABCG2 and related treatments

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9089599

Low affinity FCGR deficient mice

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8828936

Therapeutic use of SCGB3A2

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8501688

SCGB3A2 as a growth factor and anti-apoptotic agent

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8227246

Compositions of adult disc stem cells for the treatment of degenerative disc disease

DiscGenics, Inc. · Granted Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8163737

CGRP receptor antagonists

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8163294

Growth regulatable recombinant BCG compositions

The Regents of the University of California · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8133859

SCGB3A2 as a growth factor and anti-apoptotic agent

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7842686

CGRP receptor antagonists

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7834000

CGRP receptor antagonists

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6821750

ABCG8 vectors, host cells, and method of making

The Board of Regents of the University of Texas System · Granted Tue Nov 23 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6218509

LH/CG receptor, DNA and use thereof

Takeda Chemical Industries Ltd. · Granted Tue Apr 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired